Efficient induction of human CD4+ T cell lines reactive with a self-K- ras-derived peptide in vitro, using a mAb to CD29

Human Immunology

Volumn 59, Issue 6, 1998, Pages 343-351

  Tanaka, Yoshihiko ^a,b   Ogawa, Michio ^b   Nishimura, Yasuharu ^a   Matsushita, Sho ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL ADHESION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD29; ANTIGENS, CD3; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL LINE; CLONAL ANERGY; CLONE CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; RAS PROTEINS;

EID: 17144464839     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00031-7     Document Type: Article

References (41)

1. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell. 76:1994;17.
2. Sumida T., Hoa T.T., Asahara H., Hasunuma T., Nishioka K. T cell receptor of Fas-sensitive T cells in rheumatoid synovium. J Immunol. 158:1997;1965.
3. Tanaka Y., Nishimura Y., Matsushita S. T-cell functional studies effect of monoclonal antibodies to T-cell and adhesion structures on a proliferative response of a CD4-positive T-cell clone with a paracrine growth property . Kishimoto T., Kikutani H., von dem Borne A.E.G.K., Goyert S.M., Mason D.Y., Miyasaka M., Moretta L., Okumura K., Shaw S., Springer T.A., Sugamura K., Zola H. Leucocyte typing VI white cell differentiation antigens . 1997;Garland Publishing Inc, New York & London.
4. Barnes P.F., Mehra V., Rivoire B., Fong S.J., Brennan P.J., Voegtline M.S., Minden P., Houghten R.A., Bloom B.R., Modlin R.L. Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J Immunol. 148:1992;1835.
5. Kishimoto T., Kikutani H., von dem Borne A.E.G.K., Goyert S.M., Mason D.Y., Miyasaka M., Moretta L., Okumura K., Shaw S., Springer T.A., Sugamura K., Zola H. Leucocyte typing VI white cell differentiation antigens . 1997;Garland Publishing Inc, New York & London.
6. Yokomizo H., Matsushita S., Fujisao S., Murakami S., Fujita H., Shirouzu M., Yokoyama S., Ogawa M., Nishimura Y. Augmentation of immune response by an analog of the antigenic peptide in a human T-cell clone recognizing mutated ras-derived peptides. Hum Immunol. 52:1997;22.
7. + T cells specific to streptococcal antigen present in low but not in high responders. J Immunol. 146:1991;2560.
8. Ishiyama M., Miyazono Y., Sasamoto K., Ohkura Y., Ueno K. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 44:1997;1299.
9. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;477.
10. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V . J Immunol Methods. 184:1995;39.
11. Ikagawa S., Matsushita S., Chen Y.Z., Ishikawa T., Nishimura Y. Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism. J Allergy Clin Immunol. 97:1996;53.
12. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMTh, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1996. In: Charron D (ed): Proceedings of the Twelfth International Histocompatibility Workshop and Conference. Paris, Medical and Science International Publisher, 1997; Volume I, 505.
13. Sone T., Tsukamoto K., Hirayama K., Nishimura Y., Takenouchi T., Aizawa M., Sasazuki T. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules. J Immunol. 135:1985;1288.
14. Hirayama K., Nishimura Y., Tsukamoto K., Sasazuki T. Functional and molecular analysis of three distinct HLA-DR4 beta-chains responsible for the MLR between HLA-Dw4, Dw15, and DKT2. J Immunol. 137:1986;924.
15. Kasahara M., Takenouchi T., Ikeda H., Ogasawara K., Okuyama T., Ishikawa N., Wakisaka A., Kikuchi Y., Aizawa M. Serologic dissection of HLA-D specificities by the use of monoclonal antibodies II. Distinction between HLA-Dw2 and HLA-Dw12 . Immunogenetics. 18:1983;525.
16. Kasahara M., Takenouchi T., Ogasawara K., Ikeda H., Okuyama T., Ishikawa N., Moriuchi J., Wakisaka A., Kikuchi Y., Aizawa M., Kaneko T., Kashiwagi N., Nishimura Y., Sasazuki T. Serologic dissection of HLA-D specificities by the use of monoclonal antibodies. Immunogenetics. 17:1983;485.
17. Janine M.L., Paul J.T., Gordon J.F., Lee M.N., David A.H. Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med. 176:1992;177.
18. Jenkins M.K., Johnson J.G. Molecules involved in T-cell costimulation. Curr Opin Immunol. 5:1993;361.
19. Rattis F.M., Peguet-Navarro J., Staquet M.J., Dezutter-Dambuyant C., Courtellemont P., Redziniak G., Schmitt D. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol. 26:1996;449.
20. Yokozeki H., Katayama I., Ohki O., Matsunaga T., Watanabe K., Satoh T., Azuma M., Okumura K., Nishioka K. Functional CD86 (B7-2/B70) on cultured human Langerhans cells. J Invest Dermatol. 106:1996;147.
21. Schwartz R.H. Acquisition of immunologic self-tolerance. Cell. 57:1989;1073.
22. Shahinian A., Pfeffer K., Lee K.P., Kundig T.M., Kishihara K., Wakeham A., Kawai K., Ohashi P.S., Thompson C.B., Mak T.W. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 261:1993;609.
23. Ticchioni M., Aussel C., Breittmayer J.P., Manie S., Pelassy C., Bernard A. Suppressive effect of T cell proliferation via the CD29 molecule The CD29 mAb 1 "K20" decreases diacylglycerol and phosphatidic acid levels in activated T cells . J Immunol. 151:1993;119.
24. Matsushita S., Morimoto C., Schlossman S.F., Sasazuki T. Monoclonal antibody 4B4 blocks suppression of the immune response to cryptomeria japonica pollen antigen. Hum Immunol. 22:1988;1.
25. + lymphocytes. Nature. 339:1989;152.
26. Udagawa T., Woodside D.G., McIntyre B.W. α4β4 (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation. J Immunol. 157:1996;1965.
27. Ng T.T., Kanner S.B., Humphries M.J., Wickremasinghe R.G., Nye K.E., Anderson J., Khoo S.H., Morrow W.J. The integrin-triggered rescue of T lymphocyte apoptosis is blocked in HIV-1-infected individuals. J Immunol. 158:1997;2984.
28. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787.
29. Yamada A., Nojima Y., Sugita K., Dang N.H., Schlossman S.F., Morimoto C. Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system. Eur J Immunol. 21:1991;319.
30. Kubin M., Kamoun M., Trinchieri G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med. 180:1994;211.
31. Reinhold M.I., Lindberg F.P., Kersh G.J., Allen P.M., Brown E.J. Costimulation of T cell activation by Integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J Exp Med. 185:1997;1.
32. Matsushita S., Nishimura Y. Partial activation of human T cells by peptide analogs on live APC induction of clonal anergy associated with protein tyrosine dephosphorylation . Hum Immunol. 53:1997;73.
33. L. Immunity. 3:1995;87.
34. Wucherpfennig K.W., Sette A., Southwood S., Oseroff C., Matsui M., Strominger J.L., Hafler D.A. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med. 179:1994;279.
35. Yamamoto K., Fukui Y., Esaki Y., Inamitsu T., Sudo T., Yamane K., Kamikawaji N., Kimura A., Sasazuki T. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD34 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice. J Exp Med. 180:1994;165.
36. Sankhla S.K., Nadkarni J.S., Bhagwati S.N. Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors. J Neuro-Oncol. 27:1996;133.
37. Zambello R., Trentin L., Enthammer C., Cipriani A., Agostini C., Semenzato G. Lysis of pulmonary fibroblasts by lymphokine (IL-2)-activated killer cells - a mechanism affecting the human lung microenvironment? Clin Exp Immunol. 105:1996;383.
38. Bos JL: ras Oncogenes in human cancer: A review Cancer Res 49:4682, 1989. (Published erratum appears in Cancer Res 15;50:1352, 1990.).
39. Jung S., Schluesener H.J. Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J Exp Med. 173:1991;273.
40. Geede-Dahl T.D., Fossum B., Eriksen J.A., Thorsby E., Gaudernack G. T cell clones specific for p21 ras-derived peptides characterization of their fine specificity and HLA restriction . Eur J Immunol. 23:1993;754.
41. Fossum B., Breivik J., Meling G.I., Gredde-Dahl T.R., Hansen T., Knutsen I., Rognum T.O., Thorsby E., Gaudernack G. A K-ras 13Gly → Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer Modifying effect of DQ7 on established cancers harbouring this mutation? Int J Cancer. 58:1994;506.